How Hemodiafiltration Affects NGAL Production in Kidney Patients
Author Information
Author(s): Adriana Arena, Giovanna Stassi, Daniela Iannello, Domenica Gazzara, Maria Calapai, Carlo Bisignano, Davide Bolignano, Antonio Lacquaniti, Michele Buemi
Primary Institution: University of Messina
Hypothesis
Does hemodiafiltration influence the ability of polymorphonuclear granulocytes to release NGAL in chronic kidney disease patients?
Conclusion
The study found that NGAL production in healthy subjects is supported solely by IL-1β, while in hemodialysis patients, it is supported by both IL-1β and TNF-α.
Supporting Evidence
- NGAL production was significantly higher in healthy subjects compared to pre and post hemodialysis patients.
- IL-1β and TNF-α levels were higher in post-hemodialysis patients than in pre-hemodialysis patients.
- Neutralization of IL-1β reduced NGAL production in pre and post hemodialysis patients.
Takeaway
This study looked at how a treatment for kidney disease affects a protein that helps with inflammation. It found that healthy people and kidney patients produce this protein differently.
Methodology
The study involved 30 chronic hemodialysis patients and 18 healthy subjects, measuring NGAL production in response to cytokines and LPS stimulation.
Potential Biases
Potential biases may arise from the selection of participants and the specific conditions under which the study was conducted.
Limitations
The study was limited to a specific patient population and may not be generalizable to all chronic kidney disease patients.
Participant Demographics
30 chronic hemodialysis patients (16 males, 14 females) and 18 healthy subjects (10 males, 8 females), average age 55 years.
Statistical Information
P-Value
<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website